C155H136N24O13 — CID 159299449
6-[6-(4-cyclopropyl-N-methylanilino)-1-methylindazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[1-(cyclopropylmethyl)-6-(N-methylanilino)indazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[6-(3,4-dihydro-2H-quinolin-1-yl)-1-methylindazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[6-(N-ethylanilino)-1-methylindazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[1-ethyl-6-(N-methylanilino)indazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[1-(2-hydroxyethyl)-6-(N-methylanilino)indazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid (PubChem CID 159299449) has the molecular formula C155H136N24O13 and a molecular weight of 2542.95 g/mol. Its IUPAC name is 6-[6-(4-cyclopropyl-N-methylanilino)-1-methylindazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[1-(cyclopropylmethyl)-6-(N-methylanilino)indazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[6-(3,4-dihydro-2H-quinolin-1-yl)-1-methylindazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[6-(N-ethylanilino)-1-methylindazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[1-ethyl-6-(N-methylanilino)indazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[1-(2-hydroxyethyl)-6-(N-methylanilino)indazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid.
| Compound Name | 6-[6-(4-cyclopropyl-N-methylanilino)-1-methylindazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[1-(cyclopropylmethyl)-6-(N-methylanilino)indazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[6-(3,4-dihydro-2H-quinolin-1-yl)-1-methylindazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[6-(N-ethylanilino)-1-methylindazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[1-ethyl-6-(N-methylanilino)indazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[1-(2-hydroxyethyl)-6-(N-methylanilino)indazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid |
|---|---|
| PubChem CID | 159299449 |
| Molecular Formula | C155H136N24O13 |
| Molecular Weight | 2542.95 g/mol |
| Exact Mass | 2541.07 |
| IUPAC Name | 6-[6-(4-cyclopropyl-N-methylanilino)-1-methylindazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[1-(cyclopropylmethyl)-6-(N-methylanilino)indazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[6-(3,4-dihydro-2H-quinolin-1-yl)-1-methylindazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[6-(N-ethylanilino)-1-methylindazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[1-ethyl-6-(N-methylanilino)indazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid;6-[1-(2-hydroxyethyl)-6-(N-methylanilino)indazol-3-yl]-5H-cyclopenta[b]pyridine-4-carboxylic acid |
| SMILES | CCN(c1ccccc1)c1ccc2c(C3=Cc4nccc(C(=O)O)c4C3)nn(C)c2c1.CCn1nc(C2=Cc3nccc(C(=O)O)c3C2)c2ccc(N(C)c3ccccc3)cc21.CN(c1ccc(C2CC2)cc1)c1ccc2c(C3=Cc4nccc(C(=O)O)c4C3)nn(C)c2c1.CN(c1ccccc1)c1ccc2c(C3=Cc4nccc(C(=O)O)c4C3)nn(CC3CC3)c2c1.CN(c1ccccc1)c1ccc2c(C3=Cc4nccc(C(=O)O)c4C3)nn(CCO)c2c1.Cn1nc(C2=Cc3nccc(C(=O)O)c3C2)c2ccc(N3CCCc4ccccc43)cc21 |
| InChI | InChI=1S/2C27H24N4O2.C26H22N4O2.C25H22N4O3.2C25H22N4O2/c1-30(19-7-5-17(6-8-19)16-3-4-16)20-9-10-22-25(15-20)31(2)29-26(22)18-13-23-21(27(32)33)11-12-28-24(23)14-18;1-30(19-5-3-2-4-6-19)20-9-10-22-25(15-20)31(16-17-7-8-17)29-26(22)18-13-23-21(27(32)33)11-12-28-24(23)14-18;1-29-24-15-18(30-12-4-6-16-5-2-3-7-23(16)30)8-9-20(24)25(28-29)17-13-21-19(26(31)32)10-11-27-22(21)14-17;1-28(17-5-3-2-4-6-17)18-7-8-20-23(15-18)29(11-12-30)27-24(20)16-13-21-19(25(31)32)9-10-26-22(21)14-16;1-3-29(17-7-5-4-6-8-17)18-9-10-20-23(15-18)28(2)27-24(20)16-13-21-19(25(30)31)11-12-26-22(21)14-16;1-3-29-23-15-18(28(2)17-7-5-4-6-8-17)9-10-20(23)24(27-29)16-13-21-19(25(30)31)11-12-26-22(21)14-16/h5-12,14-16H,3-4,13H2,1-2H3,(H,32,33);2-6,9-12,14-15,17H,7-8,13,16H2,1H3,(H,32,33);2-3,5,7-11,14-15H,4,6,12-13H2,1H3,(H,31,32);2-10,14-15,30H,11-13H2,1H3,(H,31,32);2*4-12,14-15H,3,13H2,1-2H3,(H,30,31) |
| InChIKey | LBDJQRZHCOJCEW-UHFFFAOYSA-N |
| XLogP | 29.58 |
| TPSA | 447.73 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 192 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2542.95 |
| LogP ≤ 5 | 29.58 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 31 |